We advised the dealer managers on the tender offer

Davis Polk advised the deal managers in connection with Bristol Myers Squibb’s cash tender offer to purchase up to $7 billion aggregate principal amount of 15 series of outstanding senior notes.

Bristol Myers Squibb Company is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

The Davis Polk capital markets team included partner Richard D. Truesdell Jr., counsel Jennifer (Ying) Lan and associate Paul M. Sessa. The tax team included partner Kara L. Mungovan and associates Omar Hersi and Summer Elbardissy. All members of the Davis Polk team are based in the New York office.

Copy link to share post